These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 33558992)

  • 1. Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection.
    Das KY; Midhun Raj KT; Samprathi M; Sridhar M; Adiga R; Vemgal P
    Indian J Pediatr; 2021 May; 88(5):479. PubMed ID: 33558992
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barré Syndrome Associated with SARS-CoV-2 infection].
    Esteban Molina A; Mata Martínez M; Sánchez Chueca P; Carrillo López A; Sancho Val I; Sanjuan-Villarreal TA
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):513-514. PubMed ID: 32532531
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 associated Guillain-Barre syndrome after awaking on the ICU: consider differentials.
    Finsterer J
    Tuberk Toraks; 2021 Sep; 69(3):429-430. PubMed ID: 34581168
    [No Abstract]   [Full Text] [Related]  

  • 6. [Guillain-Barre syndrome associated with COVID-19].
    Bogdanova AA; Kravtsunova ES; Raevskaia AI; Karpov AS; Gadaborshev RN; Dzutsev AI; Vyshlova IA; Karpov SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):132-136. PubMed ID: 36168699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 9. Guillain-Barré syndrome following COVID-19: new infection, old complication?
    Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
    J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2, a new causative agent of Guillain-Barré syndrome?
    Esteban Molina A; Mata Martínez M; Sánchez Chueca P; Carrillo López A
    Med Intensiva (Engl Ed); 2022 Feb; 46(2):110-111. PubMed ID: 34887232
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guillain-Barre syndrome with cranial nerve damage as complication of COVID-19].
    Shakaryan AK; Pylaeva SK; Perekopskaya NE; Sayfullin RF; Belyakova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):100-103. PubMed ID: 34693696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome.
    Finsterer J
    J Korean Med Sci; 2022 Jul; 37(26):e217. PubMed ID: 35790211
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barré syndrome after SARS-CoV-2 infection.
    Kilinc D; van de Pasch S; Doets AY; Jacobs BC; van Vliet J; Garssen MPJ
    Eur J Neurol; 2020 Sep; 27(9):1757-1758. PubMed ID: 32533876
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome: A Rare SARS-CoV-2 Infection-Associated Neurological Complication.
    Kapoor D; Sharma S; Anand A
    Indian J Pediatr; 2022 Sep; 89(9):942. PubMed ID: 35852703
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guillain-Barré syndrome associated with SARS-CoV-2].
    Chapon F
    Med Sci (Paris); 2020 Dec; 36 Hors série n° 2():53-54. PubMed ID: 33427637
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.
    Lunn MP; Carr AC; Keddie S; Pakpoor J; Pipis M; Willison HJ
    Brain; 2021 Jun; 144(5):e47. PubMed ID: 33822006
    [No Abstract]   [Full Text] [Related]  

  • 17. Guillain-Barré Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response.
    Hughes DL; Brunn JA; Jacobs J; Todd PK; Askari FK; Fontana RJ
    Liver Transpl; 2022 Jan; 28(1):134-137. PubMed ID: 34431208
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor: Finger Extensor Weakness Is Not a Novel Clinical Feature of SARS-CoV-2 Associated Guillain-Barre Syndrome.
    Finsterer J
    J Korean Med Sci; 2022 Jul; 37(27):e223. PubMed ID: 35818707
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection.
    Civardi C; Collini A; Geda DJ; Geda C
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1361-1362. PubMed ID: 32859744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 58.